These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6278353)

  • 1. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats.
    Turkanis SA; Karler R
    Neuropharmacology; 1982 Jan; 21(1):7-13. PubMed ID: 6278353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
    Chiu P; Olsen DM; Borys HK; Karler R; Turkanis SA
    Epilepsia; 1979 Aug; 20(4):365-75. PubMed ID: 113206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic properties of the cannabinoids.
    Turkanis SA; Karler R
    J Clin Pharmacol; 1981; 21(S1):449S-463S. PubMed ID: 6271840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
    Turkanis SA; Karler R
    Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.
    Järbe TU; Hiltunen AJ; Lander N; Mechoulam R
    Pharmacol Biochem Behav; 1986 Aug; 25(2):393-9. PubMed ID: 3020594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats.
    Turkanis SA; Smiley KA; Borys HK; Olsen DM; Karler R
    Epilepsia; 1979 Aug; 20(4):351-63. PubMed ID: 477630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.
    Hiltunen AJ; Järbe TU
    Neuropharmacology; 1986 Feb; 25(2):133-42. PubMed ID: 3010159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta 1-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters.
    van Ree JM; Niesink RJ; Nir I
    Psychopharmacology (Berl); 1984; 84(4):561-5. PubMed ID: 6098915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
    Nagai K; Watanabe K; Narimatsu S; Gohda H; Matsunaga T; Yamamoto I; Yoshimura H
    Biol Pharm Bull; 1993 Oct; 16(10):1008-13. PubMed ID: 8287029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
    Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
    Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol.
    Compton DR; Little PJ; Martin BR; Gilman JW; Saha JK; Jorapur VS; Sard HP; Razdan RK
    J Med Chem; 1990 May; 33(5):1437-43. PubMed ID: 2158563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
    Zuardi AW; Teixeira NA; Karniol IC
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids.
    Turkanis SA; Karler R
    Neuropharmacology; 1988 Jul; 27(7):737-42. PubMed ID: 2901683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.
    Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL
    J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
    Turkanis SA; Chiu P; Borys HK; Karler R
    Psychopharmacology (Berl); 1977 Apr; 52(2):207-12. PubMed ID: 407606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.